RAD-140 liquid, capsules, powder and injectables in brief
One compound stands behind RAD-140 liquid, capsules, powder and injectables. A liquid carries RAD140 dissolved in a solvent such as polyethylene glycol, capsules and powder carry it as a dry solid, and an injectable carries it in solution for a syringe, so the four differ in how an amount is measured and how long they keep.
Only the oral route has data. The single human trial among this article’s sources, a RAD 140 study in patients with metastatic breast cancer, gave the compound orally once a day, and orally dosed rats and monkeys absorbed it well, whereas precipitation from solution and the difficulty of measuring a volume are known only from descriptions outside the published trials. No form escapes the question of its label: when an Australian regulator tested products sold as selective androgen receptor modulators (SARMs), it found them significantly under-dosed.
Testolone is the other name of the SARM RAD140, a nonsteroidal compound (one not built on the steroid nucleus) which its discovery paper calls a potent, orally bioavailable SARM acting at the androgen receptor, the protein inside cells that androgens activate; as vosilasarm it later went orally to patients in a phase 1 breast-cancer trial. The discovery paper and that study are the whole published record, and this comparison rests on them. Below, the four forms are set against one another by what each holds and how an amount is measured from it and how it keeps, and then against the human trial, the animal work and the regulator’s testing; of the compound’s effects, only the liver function test elevations recorded in the trial come into it.
Four RAD140 forms compared
Form
What it holds
How an amount is fixed
How it keeps
Published data on this route
Liquid
Compound dissolved in a carrier such as polyethylene glycol
Volume drawn at the labelled concentration
Shorter in solution; can precipitate or crystallise
Oral route: one human trial and rats and monkeys
Capsules
Weighed solid in a gelatin shell
Set when the capsule was filled
Dry solid, comparatively stable
Oral route: one human trial and rats and monkeys
Powder
Compound as a dry solid
Weighed on a milligram scale
Dry solid, comparatively stable
None for powder as such
Injectable
Solution in a sealed vial, or a lyophilised powder to be reconstituted
Volume drawn from the vial
In solution, or as a freeze-dried solid
None; no injected route was studied
Any form
May not match its label
Label strength unconfirmed
Not addressed
Australian testing found SARM products significantly under-dosed
Oral RAD140 in the first human trial
Three cohorts, each on a different once-daily oral dose, make up the only human record of a RAD140 dose among this article’s sources, and the table below gives each cohort’s dose and its count of patients. The participants were postmenopausal women with ER+/HER2- metastatic breast cancer, oestrogen receptor-positive and HER2-negative disease that had spread beyond the breast, in the number the table records. Escalation stopped on toxicity rather than on target engagement, and the maximum tolerated dose (the highest whose toxicity remained acceptable) was fixed at the middle cohort’s daily dose.
Once-daily dosing followed from the RAD 140 half life in the table, the elimination half-life being the time the amount of compound in the blood takes to fall by half, and an expansion cohort was enrolled to characterise that pharmacokinetic profile further. Whether the compound reached its target was read off two blood markers, sex hormone-binding globulin, which fell in all 18 patients measured, and prostate-specific antigen, which rose in 16 of 20, and tumour biopsies paired before and during treatment pointed the same way. Every one of these findings belongs to RAD 140 oral administration (the one route with human data) and to patients with advanced cancer rather than healthy adults.
Elevated liver function tests were the most frequent adverse events of the orally administered compound in that trial, and neither they nor the class warning on SARMs and the liver weigh a solution against a capsule.
Dose cohorts in the first human trial
Trial cohort (once daily, oral)
Patients
Outcome of escalation
50 mg
6
Escalation continued
100 mg
13
Fixed as maximum tolerated dose
150 mg
3
Above the maximum tolerated dose
All cohorts
22 postmenopausal women with ER+/HER2- metastatic breast cancer
How many mg are in 1 ml of liquid, and how do you measure a dose with a dropper?
In descriptions outside the trials, the amount of RAD140 in one millilitre of liquid is whatever concentration the label states, in mg of compound per millilitre, and the volume drawn fixes the mass measured; labels are often described as leaving unclear whether a strength applies per millilitre or to the whole bottle, and because bottles are supplied at several different concentrations, equal volumes drawn from two of them hold different masses, which is named again and again as a source of measuring error. A SARM certificate of analysis gives the measured concentration that a label only declares.
The dropper has also been described as the weak point in that arithmetic. Droppers supplied with bottles are sometimes unmarked or do not fill to the line, counting RAD 140 drops is a poor substitute for a measured volume, and a graduated oral syringe marked in millilitres is the dropper’s usual replacement; a bottle that runs out before the number of measures its stated volume implies turns up occasionally, as does a dropper bottle holding two compounds put into it by mistake. Most accounts of measuring a solution come from RAD-140 Reddit posts and other discussions.
Read the concentration on the label: find the strength given in mg per ml, and check that it is stated per millilitre rather than for the whole bottle.
Divide the amount by the concentration: divide the mass required, in mg, by the concentration in mg per ml; the result is the volume in ml.
Measure the volume with a graduated syringe: draw that volume with an oral syringe marked in ml, rather than counting drops or filling a dropper by eye, because the fill of a dropper varies.
Check the solution is clear first: inspect for cloudiness or crystals before drawing, because a measured volume no longer holds the stated mass once the compound has come out of solution.
Is RAD140 sold as a bottled liquid meant to be taken by mouth or injected?
Bottled RAD140 has also been described as an oral solution in a dropper bottle, injectable versions being separate products in sealed vials, and the division follows from the compound itself: the research characterises RAD140 as orally bioavailable, and the studies in animals and in patients gave it orally.
This report describes the discovery of RAD140, a potent, orally bioavailable, nonsteroidal selective androgen receptor modulator (SARM).
In descriptions beyond the trials, the two kinds of product are nonetheless confused with each other, in a vial whose intended route was unclear and in the question of whether an injectable solution could be swallowed instead; one injectable is described as a lyophilised powder, freeze-dried and meant to be reconstituted, with uncertainty over whether its intended solvent was an oil base or bacteriostatic water, whereas a premade oral solution is a complete preparation that needs nothing added, so the two kinds of product are not treated as interchangeable.
Is it better to hold liquid under the tongue or swallow it?
Outside the published trials, both routes of giving RAD140 in solution have been described about equally often: oral administration of the measured volume in a single dose, and sublingual administration, in which the solution is held beneath the tongue for a short period before it passes on to the stomach.
Beyond the trial data, descriptions take these positions on the two routes:
sublingual administration acting differently from the same solution administered orally at once, and in some accounts acting better, though descriptions do not agree on that point;
a much smaller sublingual amount matching a considerably larger oral one, a claim relayed at second hand and raised repeatedly, though no description sets out a measurement behind it;
commonly, no difference at all between the two routes, on the reasoning that the compound is absorbed by either one;
the sublingual route delivering the compound to the systemic circulation without hepatic first-pass metabolism;
the bitter taste of the carrier as the consideration that weighs most, commonly favouring rapid oral administration, with the measured volume administered at once or followed by a drink.
What does liquid RAD140 taste like?
Harsh and bitter, with a burning sensation on the tongue and in the throat, is how a RAD-140 liquid is commonly described, and the taste is put down to the carrier rather than to the compound, since the liquid form is nothing more than the solid dissolved in a solvent. What does RAD 140 taste like when the solvent changes? Ethanol-based solutions give an alcoholic burn and concentrated polyethylene glycol solutions a bitter chemical aftertaste, so no single description fits every preparation, and taste is held to say nothing about the purity or the identity of what a bottle holds.
Should RAD140 be taken with food or on an empty stomach?
Food is generally held to make little difference to RAD140, because the compound is described as orally bioavailable and as having a long elimination half-life, so the mass absorbed is not thought to depend on whether the stomach is full or empty. The solvent is another matter: a carrier-based solution is often said to sit better with food, the difference being put down to gastric irritation from the carrier. None of the studies this article draws on has compared the fed with the fasted state.
What is the difference between capsules and liquid?
Outside the trial record, the difference between capsules and RAD-140 liquid is described on these points:
how the mass is fixed, described as the difference between the two forms: a capsule, a gelatin shell holding a weighed solid, holds one amount set when it was filled, whereas a liquid holds the compound dissolved, so the amount depends on the volume drawn;
taste: capsules are widely credited with its absence as a practical advantage;
the measuring step: capsules are widely credited with the absence of any measuring step as their second practical advantage;
adjusting the amount: liquid has also been described as offering the opposite advantage, an amount that can be varied without opening anything;
speed of absorption: liquid is occasionally described as absorbed faster, though no measurement stands behind that claim.
The comparison of liquid SARMs vs pills brings with it a frequent question, whether the same amount applies across the two forms. Accounts outside the published studies describe capsules opened and part of their contents poured out by eye, a split tablet holding two compounds and the doubt whether splitting divides the two evenly, and, behind all such comparisons, the recurring question of whether a switch from one form to the other makes any difference.
Can RAD140 powder be dissolved in PEG-400, and at what concentration?
PEG-400 (polyethylene glycol 400, a low-molecular-weight grade used as a solvent) is the carrier named for RAD 140 powder more often than any other in accounts outside the published studies. The concentration of such a solution is not read from a label but worked out from the mass weighed and the volume of carrier added, and the stronger the solution planned, the more often it is described as turning cloudy or never clearing at all.
In descriptions beyond the trials the powder is weighed before mixing on a milligram scale, the mixing goes better when the carrier is warmed and the solid is first dissolved in ethanol before the polyethylene glycol is added, and the solution is made up in a single batch.
Beyond the trial data, such accounts part on whether the mixing is straightforward, some describing a solution that cleared with occasional shaking and others a solid that clumped and settled out; apart from solution the powder goes into empty capsules or is weighed out as it is, and in every one of these descriptions the handling turns on the carrier rather than on the compound.
Which solvents dissolve RAD140, and why does it fall out of solution?
Outside the published trials, RAD140 is described as dissolving in ethanol, in dimethyl sulfoxide (DMSO) and in PEG-400, and as not dissolving in propylene glycol, a related glycol used as a solvent and flavour carrier. Behind these differences lies solubility, the mass of a solid that a given volume of solvent will hold in solution, and over time its consequence is precipitation, the compound coming back out of solution as a solid.
Accounts outside the published studies describe testolone powder mixed into propylene glycol by mistake as giving a suspension of undissolved solid, cloudy throughout, and raise the question of whether shaking before each measure would keep that mixture even; poor solubility of this kind is a common difficulty with the compound, premade solutions sometimes grow crystals in the bottle after some weeks, one holding less ethanol came out uneven, and many liquid preparations combine PEG-400 with DMSO.
Can RAD140 be injected, and should it go into muscle or under the skin?
Among the effects described outside the trials, injectable RAD140 appears as a product supplied in sealed vials and given either by intramuscular injection, into skeletal muscle, or by subcutaneous injection, into the fatty tissue beneath the skin.
Beyond the trial data, the descriptions of it make these claims:
the route, with no agreement on which of those two injections it is administered by;
swelling at the injection site, described on several occasions;
the carrier, described as a more common concern than the route, since polyethylene glycol and the other solvents that dissolve the compound for oral preparations are described as questionable material for injection;
an injectable supplied as a lyophilised powder, and with it the question of whether bacteriostatic water would reconstitute it and whether that water would dissolve plain RAD-140 powder at all;
a much smaller injected amount described as matching the oral one, though explicitly as a guess;
the supposition that an injected solution would spare liver tissue.
Distrust of what a vial actually holds runs through those accounts as well, and they frame RAD 140 injectable vs oral administration in the hepatic terms of that last supposition. Not one of these claims has been measured, because the human trial and the animal work covered oral administration only.
Does liquid RAD140 have a shelf life or expiry date?
A RAD-140 liquid, like other research compounds held in a solvent, is generally held to have a limited shelf life (the period over which a preparation keeps its stated content) and to come with an expiry or retest date set by the manufacturer. Does RAD 140 expire faster in solution than as a dry solid? A solution is widely understood to expire faster and a dry powder to stay comparatively stable, because these all contribute to degradation: The RAD-140 for sale in the shop carries that date with its batch and purity data.
the solvent
air
light
heat
A sealed container kept cool and out of the light is commonly described as preserving such a solution best, and storing SARMs safely generally turns on those conditions; a solution that has changed colour, clouded or thrown a deposit is taken as degraded. Published stability data for RAD140 solutions in particular are scarce, which leaves the manufacturer’s date as the only guide available, read together with the batch’s certificate of analysis, the record of the purity and identity a laboratory found in that batch.
Is liquid RAD140 still fine after it has frozen?
Chemically, freezing is generally held to do a RAD-140 liquid no harm, since cold slows rather than accelerates the degradation of most small molecules; the problem it poses is physical, because the dissolved compound can crystallise or settle out of the usual carriers, polyethylene glycol or ethanol-based solvents, and leave a cloudy liquid or a solid at the bottom of the vessel.
Warmed gently to room temperature and mixed until clear, such a preparation is widely understood to return to a uniform solution, while one that stays cloudy, has changed colour or has taken up moisture through a poor seal can no longer be assumed to hold an even concentration; repeated freezing and thawing is for that reason held to be worse for stability than storage at one steady temperature, cool and out of the light.
Do capsules really contain the dose on the label?
Outside the published trials, capsules, like liquids, are described as not always holding what their label states, so a legit RAD 140 product cannot be told from its label alone; products sold as selective androgen receptor modulators are widely understood not to hold reliably the compound or the amount printed on the label, and capsules labelled RAD140 are no exception in those accounts.
RAD140 in solution is described, outside the trial record, as inconsistent from one bottle to the next, and these are the mismatches between label and contents those accounts describe:
a capsule product found on testing to hold mostly another SARM;
capsules holding two or three compounds at once sold under a single name;
a new bottle of solution that looked white rather than clear and differed in smell and taste from an earlier one with the same label;
two solutions from different sources, both labelled RAD140, that seemed to differ from each other;
an unclear label that stated the compound as a small percentage of the liquid;
a bag of powder that looked fuller than another labelled with the same weight.
A regulator that tested unapproved SARM products found them significantly under-dosed, whatever the form, so in those accounts a label settles nothing.
In those accounts the doubt reaches every form, and all the UK SARMs in the range come with batch and purity data.
Oral bioavailability in rats and monkeys
A potent, orally bioavailable, nonsteroidal selective androgen receptor modulator is what the paper reporting the discovery of RAD140 calls it, on the strength of work in rats and in monkeys across several preclinical models of anabolic androgen action.
What that description rests on is SARM bioavailability by the oral route, the share of an orally administered dose that reaches the systemic circulation. The animals were dosed orally, so the finding speaks to the oral route alone and offers no comparison between liquid, capsule, powder and injectable preparations.
How well is oral RAD140 absorbed?
Beyond the published trials, RAD140 administered orally is described as well absorbed, with oral bioavailability named as its defining property, and RAD140 solution swallowed as just as effective as the same solution administered sublingually. Those accounts draw a line between the amount swallowed and what reaches the androgen receptor in cells, two quantities that are not the same; the lipid solubility of the compound is left an open question, as is whether piperine (the alkaloid of black pepper) or vitamin B6 would raise its absorption, and the solution is said to be absorbed faster than a capsule, a difference stated without any measurement behind it.
What is still unknown about RAD140 forms
Any measured comparison of one form with another is what remains unknown about RAD-140 liquid, capsules, powder and injectables. The gap reflects the evidence. The one human trial of RAD140 among this article’s sources enrolled patients with metastatic breast cancer, in the number the table below records, and gave the compound orally only; oral bioavailability was shown in rats and monkeys rather than in humans; and the regulator’s finding of under-dosing covers products sold as selective androgen receptor modulators on the Australian market as a class, not one SARM at a time. None of the studies this article draws on sets one form of RAD140 against another. Liver findings belong to RAD140 liver toxicity, not to the form.
What each source covers on RAD140 forms
Source
Kind of evidence
Population or scope
Route covered
Compares forms?
Phase 1 trial, 2022
First-in-human dose escalation
22 women with metastatic breast cancer
Oral only
No
Discovery paper, 2011
Preclinical characterisation
Rats and monkeys
Oral only
No
LiverTox monograph
Drug-induced liver injury reference
SARM class as a whole
None named
No
TGA safety alert
Regulatory product testing
Unapproved SARM products, Australian market
Not applicable
No; found significant under-dosing across products
Four matters are known only from descriptions outside the trials: precipitation in some carriers, a difference between solution held sublingually and solution swallowed at once, swelling at injection sites, and contents that differ from the label. No published study among this article’s sources has measured any of these four matters.
Important information. This article summarises published research and case reports, and notes where effects are described outside the published trials. It is not medical advice, and Max Muscle Labs does not give dosing guidance or any information implying human use. Many of the compounds discussed here are not approved for human use by the MHRA, the FDA or any other regulator, and many are prohibited in sport by WADA. Products sold by Max Muscle Labs are supplied strictly for laboratory and analytical research use and are not for human or veterinary consumption.
Check what you remember
4 questions on this article; the right answer is marked.
Which route of administering RAD140 has published data behind it among the article's sources?
Orally, in one human trial and in animals ✓
Sublingually, in a trial against oral solution
Intramuscularly, in studies of rats and monkeys
Subcutaneously, in a small human trial
The only human trial gave RAD140 orally, as did the rat and monkey work, and no injected or sublingual route was studied.
In the first human trial of RAD140, which adverse events were the most frequent?
Vomiting together with a loss of appetite
Rises in liver enzymes such as AST and ALT ✓
Low blood phosphate in most of the patients
Raised blood pressure and a faster heart rate
AST rose in 59.1% and ALT in 45.5% of the 22 patients, ahead of vomiting and appetite loss at 27.3% each.
What did Australia's medicines regulator find when it tested products sold as SARMs?
Products held more compound than labelled
Capsules matched their labels; liquids fell short
Products held significantly less than labelled ✓
Products matched labels within normal limits
The TGA found that unapproved SARM products on the Australian market held significantly less than their labels stated.
What does the published research say about how the four forms of RAD140 compare?
A study found injected RAD140 spares the liver
A study found liquid absorbed faster than capsules
A study found sublingual liquid absorbed best of all
No study in the sources compares the forms directly ✓
The one human trial used the oral route only, so claims about sublingual, injected or faster-absorbed forms rest on no measurement.
Research Fellow in Digital Drug Product Development
Bilal Ahmed is a research fellow in digital drug product development at CMAC, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde. Bilal specialises in formulation science.
Lecturer in Analytical Chemistry; Biochemistry course leader
Alexandra Males is a lecturer in analytical chemistry and the biochemistry course leader at Sheffield Hallam University. Alexandra specialises in analytical chemistry, HPLC and chromatography, mass spectrometry, reference standards and metrology, and stability and impurity profiling.
MK677 liquid is ibutamoren powder dissolved in a solvent, the same compound as capsules, and no stability study of a finished bottle backs its storage.
Legit RAD 140 is shown only by a lab test of the bottle’s batch, as analyses found products missing the compound, under-strength or with other hormones.
Hurry while stocks last! Use code PAYDAY15 at checkout to get 15% off sitewide. Valid for
Join the WaitlistWe will inform you when the product is back in stock. Enter your email address below.
RAD 140 liquid: capsules, powder and injectables compared
By Bilal Ahmed, PhD · Reviewed by Alexandra Males, PhD
Published · Updated · 19 min read
RAD-140 liquid, capsules, powder and injectables in brief
One compound stands behind RAD-140 liquid, capsules, powder and injectables. A liquid carries RAD140 dissolved in a solvent such as polyethylene glycol, capsules and powder carry it as a dry solid, and an injectable carries it in solution for a syringe, so the four differ in how an amount is measured and how long they keep.
Only the oral route has data. The single human trial among this article’s sources, a RAD 140 study in patients with metastatic breast cancer, gave the compound orally once a day, and orally dosed rats and monkeys absorbed it well, whereas precipitation from solution and the difficulty of measuring a volume are known only from descriptions outside the published trials. No form escapes the question of its label: when an Australian regulator tested products sold as selective androgen receptor modulators (SARMs), it found them significantly under-dosed.
Testolone is the other name of the SARM RAD140, a nonsteroidal compound (one not built on the steroid nucleus) which its discovery paper calls a potent, orally bioavailable SARM acting at the androgen receptor, the protein inside cells that androgens activate; as vosilasarm it later went orally to patients in a phase 1 breast-cancer trial. The discovery paper and that study are the whole published record, and this comparison rests on them. Below, the four forms are set against one another by what each holds and how an amount is measured from it and how it keeps, and then against the human trial, the animal work and the regulator’s testing; of the compound’s effects, only the liver function test elevations recorded in the trial come into it.
Four RAD140 forms compared
Oral RAD140 in the first human trial
Three cohorts, each on a different once-daily oral dose, make up the only human record of a RAD140 dose among this article’s sources, and the table below gives each cohort’s dose and its count of patients. The participants were postmenopausal women with ER+/HER2- metastatic breast cancer, oestrogen receptor-positive and HER2-negative disease that had spread beyond the breast, in the number the table records. Escalation stopped on toxicity rather than on target engagement, and the maximum tolerated dose (the highest whose toxicity remained acceptable) was fixed at the middle cohort’s daily dose.
Once-daily dosing followed from the RAD 140 half life in the table, the elimination half-life being the time the amount of compound in the blood takes to fall by half, and an expansion cohort was enrolled to characterise that pharmacokinetic profile further. Whether the compound reached its target was read off two blood markers, sex hormone-binding globulin, which fell in all 18 patients measured, and prostate-specific antigen, which rose in 16 of 20, and tumour biopsies paired before and during treatment pointed the same way. Every one of these findings belongs to RAD 140 oral administration (the one route with human data) and to patients with advanced cancer rather than healthy adults.
Elevated liver function tests were the most frequent adverse events of the orally administered compound in that trial, and neither they nor the class warning on SARMs and the liver weigh a solution against a capsule.
Dose cohorts in the first human trial
How many mg are in 1 ml of liquid, and how do you measure a dose with a dropper?
In descriptions outside the trials, the amount of RAD140 in one millilitre of liquid is whatever concentration the label states, in mg of compound per millilitre, and the volume drawn fixes the mass measured; labels are often described as leaving unclear whether a strength applies per millilitre or to the whole bottle, and because bottles are supplied at several different concentrations, equal volumes drawn from two of them hold different masses, which is named again and again as a source of measuring error. A SARM certificate of analysis gives the measured concentration that a label only declares.
The dropper has also been described as the weak point in that arithmetic. Droppers supplied with bottles are sometimes unmarked or do not fill to the line, counting RAD 140 drops is a poor substitute for a measured volume, and a graduated oral syringe marked in millilitres is the dropper’s usual replacement; a bottle that runs out before the number of measures its stated volume implies turns up occasionally, as does a dropper bottle holding two compounds put into it by mistake. Most accounts of measuring a solution come from RAD-140 Reddit posts and other discussions.
Is RAD140 sold as a bottled liquid meant to be taken by mouth or injected?
Bottled RAD140 has also been described as an oral solution in a dropper bottle, injectable versions being separate products in sealed vials, and the division follows from the compound itself: the research characterises RAD140 as orally bioavailable, and the studies in animals and in patients gave it orally.
In descriptions beyond the trials, the two kinds of product are nonetheless confused with each other, in a vial whose intended route was unclear and in the question of whether an injectable solution could be swallowed instead; one injectable is described as a lyophilised powder, freeze-dried and meant to be reconstituted, with uncertainty over whether its intended solvent was an oil base or bacteriostatic water, whereas a premade oral solution is a complete preparation that needs nothing added, so the two kinds of product are not treated as interchangeable.
Is it better to hold liquid under the tongue or swallow it?
Outside the published trials, both routes of giving RAD140 in solution have been described about equally often: oral administration of the measured volume in a single dose, and sublingual administration, in which the solution is held beneath the tongue for a short period before it passes on to the stomach.
Beyond the trial data, descriptions take these positions on the two routes:
What does liquid RAD140 taste like?
Harsh and bitter, with a burning sensation on the tongue and in the throat, is how a RAD-140 liquid is commonly described, and the taste is put down to the carrier rather than to the compound, since the liquid form is nothing more than the solid dissolved in a solvent. What does RAD 140 taste like when the solvent changes? Ethanol-based solutions give an alcoholic burn and concentrated polyethylene glycol solutions a bitter chemical aftertaste, so no single description fits every preparation, and taste is held to say nothing about the purity or the identity of what a bottle holds.
Should RAD140 be taken with food or on an empty stomach?
Food is generally held to make little difference to RAD140, because the compound is described as orally bioavailable and as having a long elimination half-life, so the mass absorbed is not thought to depend on whether the stomach is full or empty. The solvent is another matter: a carrier-based solution is often said to sit better with food, the difference being put down to gastric irritation from the carrier. None of the studies this article draws on has compared the fed with the fasted state.
What is the difference between capsules and liquid?
Outside the trial record, the difference between capsules and RAD-140 liquid is described on these points:
The comparison of liquid SARMs vs pills brings with it a frequent question, whether the same amount applies across the two forms. Accounts outside the published studies describe capsules opened and part of their contents poured out by eye, a split tablet holding two compounds and the doubt whether splitting divides the two evenly, and, behind all such comparisons, the recurring question of whether a switch from one form to the other makes any difference.
Can RAD140 powder be dissolved in PEG-400, and at what concentration?
PEG-400 (polyethylene glycol 400, a low-molecular-weight grade used as a solvent) is the carrier named for RAD 140 powder more often than any other in accounts outside the published studies. The concentration of such a solution is not read from a label but worked out from the mass weighed and the volume of carrier added, and the stronger the solution planned, the more often it is described as turning cloudy or never clearing at all.
In descriptions beyond the trials the powder is weighed before mixing on a milligram scale, the mixing goes better when the carrier is warmed and the solid is first dissolved in ethanol before the polyethylene glycol is added, and the solution is made up in a single batch.
Beyond the trial data, such accounts part on whether the mixing is straightforward, some describing a solution that cleared with occasional shaking and others a solid that clumped and settled out; apart from solution the powder goes into empty capsules or is weighed out as it is, and in every one of these descriptions the handling turns on the carrier rather than on the compound.
Which solvents dissolve RAD140, and why does it fall out of solution?
Outside the published trials, RAD140 is described as dissolving in ethanol, in dimethyl sulfoxide (DMSO) and in PEG-400, and as not dissolving in propylene glycol, a related glycol used as a solvent and flavour carrier. Behind these differences lies solubility, the mass of a solid that a given volume of solvent will hold in solution, and over time its consequence is precipitation, the compound coming back out of solution as a solid.
Accounts outside the published studies describe testolone powder mixed into propylene glycol by mistake as giving a suspension of undissolved solid, cloudy throughout, and raise the question of whether shaking before each measure would keep that mixture even; poor solubility of this kind is a common difficulty with the compound, premade solutions sometimes grow crystals in the bottle after some weeks, one holding less ethanol came out uneven, and many liquid preparations combine PEG-400 with DMSO.
Can RAD140 be injected, and should it go into muscle or under the skin?
Among the effects described outside the trials, injectable RAD140 appears as a product supplied in sealed vials and given either by intramuscular injection, into skeletal muscle, or by subcutaneous injection, into the fatty tissue beneath the skin.
Beyond the trial data, the descriptions of it make these claims:
Distrust of what a vial actually holds runs through those accounts as well, and they frame RAD 140 injectable vs oral administration in the hepatic terms of that last supposition. Not one of these claims has been measured, because the human trial and the animal work covered oral administration only.
Does liquid RAD140 have a shelf life or expiry date?
A RAD-140 liquid, like other research compounds held in a solvent, is generally held to have a limited shelf life (the period over which a preparation keeps its stated content) and to come with an expiry or retest date set by the manufacturer. Does RAD 140 expire faster in solution than as a dry solid? A solution is widely understood to expire faster and a dry powder to stay comparatively stable, because these all contribute to degradation: The RAD-140 for sale in the shop carries that date with its batch and purity data.
A sealed container kept cool and out of the light is commonly described as preserving such a solution best, and storing SARMs safely generally turns on those conditions; a solution that has changed colour, clouded or thrown a deposit is taken as degraded. Published stability data for RAD140 solutions in particular are scarce, which leaves the manufacturer’s date as the only guide available, read together with the batch’s certificate of analysis, the record of the purity and identity a laboratory found in that batch.
Is liquid RAD140 still fine after it has frozen?
Chemically, freezing is generally held to do a RAD-140 liquid no harm, since cold slows rather than accelerates the degradation of most small molecules; the problem it poses is physical, because the dissolved compound can crystallise or settle out of the usual carriers, polyethylene glycol or ethanol-based solvents, and leave a cloudy liquid or a solid at the bottom of the vessel.
Warmed gently to room temperature and mixed until clear, such a preparation is widely understood to return to a uniform solution, while one that stays cloudy, has changed colour or has taken up moisture through a poor seal can no longer be assumed to hold an even concentration; repeated freezing and thawing is for that reason held to be worse for stability than storage at one steady temperature, cool and out of the light.
Do capsules really contain the dose on the label?
Outside the published trials, capsules, like liquids, are described as not always holding what their label states, so a legit RAD 140 product cannot be told from its label alone; products sold as selective androgen receptor modulators are widely understood not to hold reliably the compound or the amount printed on the label, and capsules labelled RAD140 are no exception in those accounts.
RAD140 in solution is described, outside the trial record, as inconsistent from one bottle to the next, and these are the mismatches between label and contents those accounts describe:
A regulator that tested unapproved SARM products found them significantly under-dosed, whatever the form, so in those accounts a label settles nothing.
In those accounts the doubt reaches every form, and all the UK SARMs in the range come with batch and purity data.
Oral bioavailability in rats and monkeys
A potent, orally bioavailable, nonsteroidal selective androgen receptor modulator is what the paper reporting the discovery of RAD140 calls it, on the strength of work in rats and in monkeys across several preclinical models of anabolic androgen action.
What that description rests on is SARM bioavailability by the oral route, the share of an orally administered dose that reaches the systemic circulation. The animals were dosed orally, so the finding speaks to the oral route alone and offers no comparison between liquid, capsule, powder and injectable preparations.
How well is oral RAD140 absorbed?
Beyond the published trials, RAD140 administered orally is described as well absorbed, with oral bioavailability named as its defining property, and RAD140 solution swallowed as just as effective as the same solution administered sublingually. Those accounts draw a line between the amount swallowed and what reaches the androgen receptor in cells, two quantities that are not the same; the lipid solubility of the compound is left an open question, as is whether piperine (the alkaloid of black pepper) or vitamin B6 would raise its absorption, and the solution is said to be absorbed faster than a capsule, a difference stated without any measurement behind it.
What is still unknown about RAD140 forms
Any measured comparison of one form with another is what remains unknown about RAD-140 liquid, capsules, powder and injectables. The gap reflects the evidence. The one human trial of RAD140 among this article’s sources enrolled patients with metastatic breast cancer, in the number the table below records, and gave the compound orally only; oral bioavailability was shown in rats and monkeys rather than in humans; and the regulator’s finding of under-dosing covers products sold as selective androgen receptor modulators on the Australian market as a class, not one SARM at a time. None of the studies this article draws on sets one form of RAD140 against another. Liver findings belong to RAD140 liver toxicity, not to the form.
What each source covers on RAD140 forms
Four matters are known only from descriptions outside the trials: precipitation in some carriers, a difference between solution held sublingually and solution swallowed at once, swelling at injection sites, and contents that differ from the label. No published study among this article’s sources has measured any of these four matters.
Check what you remember
4 questions on this article; the right answer is marked.
The only human trial gave RAD140 orally, as did the rat and monkey work, and no injected or sublingual route was studied.
AST rose in 59.1% and ALT in 45.5% of the 22 patients, ahead of vomiting and appetite loss at 27.3% each.
The TGA found that unapproved SARM products on the Australian market held significantly less than their labels stated.
The one human trial used the oral route only, so claims about sublingual, injected or faster-absorbed forms rest on no measurement.
Bilal Ahmed, PhD · University of Strathclyde
Research Fellow in Digital Drug Product Development
Bilal Ahmed is a research fellow in digital drug product development at CMAC, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde. Bilal specialises in formulation science.
Alexandra Males, PhD · Sheffield Hallam University · Last reviewed
Lecturer in Analytical Chemistry; Biochemistry course leader
Alexandra Males is a lecturer in analytical chemistry and the biochemistry course leader at Sheffield Hallam University. Alexandra specialises in analytical chemistry, HPLC and chromatography, mass spectrometry, reference standards and metrology, and stability and impurity profiling.
Related Posts
MK677 liquid: capsules, powder, injectables and storage
MK677 liquid is ibutamoren powder dissolved in a solvent, the same compound as capsules, and no stability study of a finished bottle backs its storage.
Legit RAD 140: fakes, under-strength products and lab tests
Legit RAD 140 is shown only by a lab test of the bottle’s batch, as analyses found products missing the compound, under-strength or with other hormones.